![Mahesh Asawa Chandra](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mahesh Asawa Chandra
Direktor/Vorstandsmitglied bei Unidrug Innovative Pharma Technologies Ltd.
Aktive Positionen von Mahesh Asawa Chandra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
![]() Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Direktor/Vorstandsmitglied | 20.09.2018 | - |
Independent Dir/Board Member | 23.08.2019 | - | |
The Institute of Chartered Accountants of India | Corporate Officer/Principal | - | - |
Karriereverlauf von Mahesh Asawa Chandra
Ausbildung von Mahesh Asawa Chandra
Devi Ahilya University | Graduate Degree |
Statistik
International
Indien | 4 |
Operativ
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Unidrug Innovative Pharma Technologies Ltd.
![]() Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
- Börse
- Insiders
- Mahesh Asawa Chandra
- Erfahrung